Phase 3 Validation of Biomarkers for the Early Detection of ER+ Breast Cancer

Abbreviated Name
Phase 3 Validation of Biomarkers for the Early Detection of ER+ Breast Cancer
Lead Investigator
Li, ChristopherFred Hutchinson Cancer Center
Coordinating Investigator
No coordinating investigator
Involved Investigators

Abstact

Aims

Analytic Method

Biomarkers

  • No biomarkers available at this time for this protocol

Data Collections

  • No data available at this time for this protocol
Protocol ID
528
Protocol Type
Single
Field of Research
UNKNOWN
Collaborative Group
Breast and Gynecologic Cancers Research Group
Cancer Types
  • Malignant neoplasm of breast

Associated Forms